Introduction to Celdara Medical and open innovation

Speaker: Celdara Medical

Intellectual property: Provisionals to granted patents including important timelines

Speaker: Christopher I. Halliday, Partner at Morgan Lewis

Regulatory requirements in drug development

Speaker: Emmanuelle Voisin, CEO at Voisin Consulting

The role of the University TTO and licensing agreements

Speaker: Alan Belicha, BD Manager at Mount Sinai Innovation Partners

When and Why to do an initial public offering (IPO)

Speaker: Jean-Loup Romet-Lemonne, Celdara Medical and Institute Pasteur

How to ‘value’ an early stage asset: Discount cash flow analysis for early-stage assets

Speaker: Sam Hall, Principal at Apple Tree Partners

Financing to Proof of Concept & Term Sheet discussion

Speaker: David Darst, COO at Rgenix

Open Forum – discussion of pitch

Speaker: Celdara Medical. *Organize a separate time to work with JLRL on pitch

Marketing analysis: How to determine the value of an asset in the market place

Speaker: Olivier Lesueur, Managing Director at Bionest Partners

Project pitch day

Judges’ Panel:
Kathleen Denis, Associate VP at Rockefeller University;
Peter Donnelly, Director at OITD Stony Brook University & Manager of Accelerate LI;
Sam Kongsamut, Executive Director at Insitute For Life Science Entrepreneurship (ILSE)
Derek Brand, CEO at Quicksilver Genomics
Sam Hall, Principal at Apple Tree Partners **
Bruce Conway, Program Director at Rockefeller University
Chris Halliday, Partner at Morgan, Lewis & Bockius

Thank you to all of the Pitch Competition participants!

Congratulations to our winners:

Natalia Frias-Staheli and Raymond Alvarez
Img 5773
Pitch Competition sponsored by:
Genmab Logo 1